| |
| |
|
| Insider
Information: |
Huizenga Theodore Alan |
| Relationship: |
|
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
41,366 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,727,858 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
41,366 |
|
|
| Total
Value |
$1,727,858 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
9
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
9
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-9.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -278.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ultragenyx Pharmaceutical Inc |
RARE |
|
2024-04-16 |
41,366 |
2015-03-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
80 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2023-04-16 |
4 |
D |
$38.20 |
$535 |
D/D |
(14) |
27,701 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2024-04-16 |
4 |
D |
$42.31 |
$592 |
D/D |
(14) |
41,366 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2023-03-01 |
4 |
S |
$45.65 |
$4,565 |
D/D |
(100) |
23,048 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
VP, Controller and PAO |
• – – |
2018-03-01 |
4 |
D |
$48.43 |
$5,327 |
D/D |
(110) |
10,675 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2024-03-01 |
4 |
D |
$53.69 |
$6,496 |
D/D |
(121) |
41,721 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2022-04-16 |
4 |
S |
$84.55 |
$11,161 |
D/D |
(132) |
16,914 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
VP, Controller and PAO |
• – – |
2019-04-19 |
4 |
D |
$64.43 |
$8,891 |
D/D |
(138) |
15,504 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Controller and PAO |
• – – |
2020-05-06 |
4 |
D |
$66.26 |
$9,144 |
D/D |
(138) |
19,680 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Controller and PAO |
• – – |
2020-04-19 |
4 |
D |
$58.57 |
$8,200 |
D/D |
(140) |
19,818 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2021-10-14 |
4 |
S |
$81.14 |
$11,360 |
D/D |
(140) |
14,072 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2021-05-06 |
4 |
S |
$113.67 |
$16,141 |
D/D |
(142) |
15,031 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Controller and PAO |
• – – |
2020-10-14 |
4 |
S |
$87.98 |
$12,845 |
D/D |
(146) |
16,436 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
VP, Controller and PAO |
• – – |
2018-05-21 |
4 |
D |
$64.79 |
$10,107 |
D/D |
(156) |
11,711 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
VP, Controller and PAO |
• – – |
2019-05-21 |
4 |
D |
$59.50 |
$9,282 |
D/D |
(156) |
16,418 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Controller and PAO |
• – – |
2016-05-21 |
4 |
D |
$64.01 |
$10,626 |
D/D |
(166) |
4,334 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
VP, Controller and PAO |
• – – |
2017-05-21 |
4 |
D |
$57.47 |
$9,540 |
D/D |
(166) |
9,846 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2023-04-16 |
4 |
D |
$38.20 |
$6,914 |
D/D |
(181) |
27,520 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
VP, Controller and PAO |
• – – |
2019-03-01 |
4 |
D |
$67.55 |
$16,617 |
D/D |
(246) |
15,649 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
VP, Controller and PAO |
• – – |
2019-03-05 |
4/A |
S |
$65.52 |
$16,642 |
D/D |
(254) |
15,642 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Controller and PAO |
• – – |
2020-05-26 |
4 |
AS |
$74.93 |
$19,482 |
D/D |
(260) |
18,331 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2024-03-01 |
4 |
S |
$53.76 |
$18,332 |
D/D |
(341) |
41,380 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Controller and PAO |
• – – |
2020-03-01 |
4 |
D |
$56.08 |
$21,759 |
D/D |
(388) |
17,058 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
VP, Controller and PAO |
• – – |
2018-05-25 |
4 |
D |
$67.31 |
$29,145 |
D/D |
(433) |
11,278 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
VP, Controller and PAO |
• – – |
2019-05-25 |
4 |
D |
$57.18 |
$24,759 |
D/D |
(433) |
15,985 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Controller and PAO |
• – – |
2020-05-25 |
4 |
D |
$73.81 |
$31,960 |
D/D |
(433) |
18,591 |
0 |
- |
|
80 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
